Clinical Trial Update: Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy of dose intensification in non-metastatic Ewing sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Snippet

Sponsor: Italian Sarcoma Group | Conditions: Ewing's Sarcoma | Phase 3 | Status: COMPLETED